Dr. Salha Bujassoum Al Bader
Medical Oncologist/Hematologist
Chairperson of Medical Oncology and Palliative Care Medicine
Director of Cancer Genetic
Clinical Lead of Breast Cancer Subspeciality
Associate Professor - Qatar University - Medical College
Clinical Faculty for Master of Genetic Counselling - Qatar University
Dr. Salha Bujassou obtained Bachelor of Medicine and Bachelor of Surgery from King Saud University in Riyadh, Saudi Arabia, in 1992. Finished post-graduate studies in Canada and received the Specialty Certificate in Internal Medicine/Hematology from the Royal College of Physicians and Surgeons of Canada, Toronto, Canada, in 2000. Obtained additional certification by the American Board of Internal Medicine/Clinical Hematology and Medical Oncology, Toronto, Canada, in 2000/2001/2004. Master of Molecular Oncology: Molecular Basis of Cancer CEB/European School of Oncology 2018
She was appointed as Consultant in Haematology/Oncology in Hamad General Hospital from February 2003 to 2005, then promoted as Sr. Consultant in Haematology/Oncology in NCCCR in 2005.
She is a member of International Oncology Societies such as ESMO, ASCO, and the International Agency for Research on Cancer (IARC) Scientific Council and has served on many HMC committees.
Her research activities focused in breast, gynecological malignancy, and cancer genetics. She has multiple active grants from QNRF. She has been an author of several publications and guidelines.
She established numerous services unique to the cancer program; one of those is ACGME-I Accredited Medical Oncology Fellowship. She is a founder of hospital-based standard risk Breast Cancer Screening in 2008, founder of Hereditary Cancer Genetic Program in 2013, and Breast Tumour Board in 2005.
In addition, Dr. Bujassoum has been Chair of the Annual Breast Cancer Conference's Organizing Committee, which has been held regularly in October for the last seven consecutive years.
